5 completed, 2 terminated. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Terminated 2 |
Follow Cocaine Abuse: new trials by email Literature Review of Cocaine Abuse trials Research Report on Cocaine Abuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) TNX-1300 (Injection), Placebo (Injection) - Cocaine Use, Cocaine Intoxication | Phase 2 | Terminated | Tonix Pharmaceuticals, Inc. | 3 | 2024-08-16 | 2025-06-24 |
| Abstinence-Linked Money Management Multisite ATM, Individual Drug Counseling - Dual Diagnosis, Cocaine Abuse | Phase 2 | Completed | Yale University | 108 | 2009-12-01 | 2020-03-30 |
| Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8 Modafinil 200mg, Modafinil 400mg, Citalopram 20mg - Cocaine Abuse, Opiate Dependence | Phase 2 | Terminated | The University of Texas Health Science Center, Houston | 54 | 2006-07-01 | 2018-11-16 |
| Medications for Stopping Cocaine Dependence and Preventing Relapse Modafinil, Levodopa/Carbidopa, Naltrexone HCl - Cocaine Abuse, Cocaine-Related Disorders | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 101 | 2006-03-01 | 2017-06-09 |
| Effects of Aripiprazole on Cocaine Craving and Self-Administration Aripiprazole + Cocaine, Placebo + Cocaine - Cocaine Abuse | Phase 2 | Completed | New York State Psychiatric Institute | 26 | 2005-04-01 | 2017-09-11 |
| Therapeutic Substance Abuse Treatment in Pregnancy - 1 MI-CBT, Brief Advice - Alcohol Abuse, Cocaine Abuse | Phase 2 | Completed | Yale University | 168 | 2004-09-01 | 2020-04-15 |
| Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence Levodopa, Carbidopa, Clinical Management - Cocaine Abuse, Cocaine-Related Disorders | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 200 | 2000-03-01 | 2016-01-05 |
Cocaine-Related Disorders (7) · Alcoholism (1) · Emergencies (1) · Marijuana Abuse (1) · Opioid-Related Disorders (1) · Substance-Related Disorders (1)
Chemically-Induced Disorders (7) · Mental Disorders (7) · Substance-Related Disorders (6) · Alcohol-Related Disorders (1) · Disease Attributes (1) · Narcotic-Related Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Modafinil (2) · Aripiprazole (1) · Carbidopa (1) · Citalopram (1) · Cocaine (1) · Cognitive Behavioral Therapy (1) · Crisis Intervention (1) · Exercise (1) · Injections (1) · Levodopa (1) · Motivational Interviewing (1) · Naltrexone (1) · Secondary Prevention (1) · carbidopa, levodopa drug combination (1) · cocaine esterase (1)
The University of Texas Health Science Center, Houston (3) · Yale University (2) · New York State Psychiatric Institute (1) · Tonix Pharmaceuticals, Inc. (1)
United States (7)
Joy M Schmitz, PhD (2) · F. Gerard Moeller, M.D. (1) · Gregory Sullivan, MD (1) · John Grabowski, PhD (1) · Kimberly A Yonkers, M.D. (1) · Marc I Rosen, M.D. (1) · Margaret Haney, Ph.D. (1)
PMID 22795046, PMID 24424425, PMID 24447885, PMID 28270105
P50DA009262 (3), R01DA012952 (1), R01DA019135 (1), U01DA056245 (1)